Breaking News

ORTHO Optix Reader Receives CE Mark and Available in Countries That Accept the CE Mark

"The ORTHO Optix Reader allows transfusion medicine labs with smaller testing volumes the same high-quality, consistent results demonstrated from the award-winning, fully automated ORTHO VISION Analyzer," said Bob Stowers, Ortho's head of transfusion medicine product portfolio.

Medtronic and the Medtronic Foundation Announce Additional and Generous $3.8 Mil Commitment to Protect and Support Healthcare Workers During COVID-19

"As the coronavirus pandemic surges around the world and in our own backyard, healthcare, food assistance, and mental health pressures are at all-time highs; it is crucial for us to deliver support quickly to counteract the disproportionate effect the virus has on underserved, marginalized communities," said Paurvi Bhatt, president of the Medtronic Foundation. "In this season of giving, we are also turning our gratitude into action by coming together with our partners to support these issues and the brave frontline health workers who are in need of services themselves."

Canon Medical at RSNA 2020: Virtual Showcases Aquilion ONE / PRISM Edition, AUTOStroke Solution, Compressed SPEEDER

Canon Medical at RSNA 2020 Breaking News: To meet the growing cardiovascular needs of healthcare providers today, Canon Medical Systems USA, Inc. is breaking ground once again with the introduction of Deep Learning Spectral CT for cardiovascular imaging and more!

3M and Rad AI Team Up to Offer Rad AI’s Advanced Technology for Generating Customized Radiology Reporting

November 30, 2020 3M and Rad AI goals: “Rad AI and 3M share a common goal of helping radiology teams become stronger and more resilient...

Samsung Introduces Its Latest Radiology Innovations at RSNA 2020

Samsung to highlight its medical imaging portfolio with its latest radiology innovations in ultrasound, digital radiography and mobile computed tomography.

12-Month Data Published in the American Journal of Respiratory and Critical Care Medicine, Demonstrate the Safety and Feasibility of RheOx ™ Bronchial Rheoplasty System for Chronic Bronchitis

September 3, 2020

RheoOX: 12-month data published in the American Journal of Respiratory and Critical Care Medicine, the official journal of the American Thoracic Society, demonstrates the safety and feasibility of the RheOxBronchial Rheoplasty System for chronic bronchitis as reported by Gala Therapeutics, developer of medical devices to treat pulmonary disease.

The prospective multi-center study evaluated the use of RheOx in patients with moderate to severe chronic bronchitis, a phenotype of Chronic Obstructive Pulmonary Disease (COPD), which affects more than 9 million Americans. The study assessed safety, changes in airway histopathology and quality of life.  Performed using a minimally invasive bronchoscopic procedure called Bronchial Rheoplasty, the RheOx System delivers non-thermal pulsed energy to the airways in the lungs to reduce mucus-producing cells, improving the symptoms of cough and mucus.

“Chronic bronchitis is a debilitating disease that severely impacts a patient’s quality of life, and there is little we can do to treat these patients today,” said Arschang Valipour, MD, FCCP, Associate Professor, Karl-Landsteiner-Institute for Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Wien, Austria. “These study results demonstrate the technical feasibility of the procedure and a favorable safety profile.  The improvements in symptoms and quality of life are compelling.”

Bronchial Rheoplasty was performed successfully in 30 patients from five centers, with no device-related serious adverse events.  Clinically meaningful improvements in quality of life were demonstrated through 12 months as measured using the COPD Assessment Test (CAT) and St. George’s Respiratory Questionnaire (SGRQ). Mean reductions from baseline in the CAT and SGRQ total scores were 7.0 and 15.2 points, respectively, exceeding the minimal clinically important differences of 2 points for CAT and 4 points for the SGRQ.  These improvements were driven by a 28% reduction in cough and 41% reduction in mucus symptoms. Histopathological analysis of the airway mucosa showed a 39% reduction in mucus-producing goblet cell hyperplasia scores in the airways.

“There is a significant unmet need for a therapy that can improve the quality of life for chronic bronchitis patients,” said Jonathan Waldstreicher, MD, CEO of Gala Therapeutics. “We are pleased with the results and are dedicated to continuing to build the clinical evidence for this therapy.”

Latest Posts

ORTHO Optix Reader Receives CE Mark and Available in Countries That Accept the CE Mark

"The ORTHO Optix Reader allows transfusion medicine labs with smaller testing volumes the same high-quality, consistent results demonstrated from the award-winning, fully automated ORTHO VISION Analyzer," said Bob Stowers, Ortho's head of transfusion medicine product portfolio.

Medtronic and the Medtronic Foundation Announce Additional and Generous $3.8 Mil Commitment to Protect and Support Healthcare Workers During COVID-19

"As the coronavirus pandemic surges around the world and in our own backyard, healthcare, food assistance, and mental health pressures are at all-time highs; it is crucial for us to deliver support quickly to counteract the disproportionate effect the virus has on underserved, marginalized communities," said Paurvi Bhatt, president of the Medtronic Foundation. "In this season of giving, we are also turning our gratitude into action by coming together with our partners to support these issues and the brave frontline health workers who are in need of services themselves."

Canon Medical at RSNA 2020: Virtual Showcases Aquilion ONE / PRISM Edition, AUTOStroke Solution, Compressed SPEEDER

Canon Medical at RSNA 2020 Breaking News: To meet the growing cardiovascular needs of healthcare providers today, Canon Medical Systems USA, Inc. is breaking ground once again with the introduction of Deep Learning Spectral CT for cardiovascular imaging and more!

iHeartMedia Los Angeles’ KOST 103.5 to Join Children’s Hospital Los Angeles for Fifth Annual Giving Tuesday Fundraising Event

Starting with The Ellen K Morning Show, nationally syndicated on 40 stations, KOST 103.5 will dedicate 12 hours of programming to Giving Tuesday and highlight the world-class pediatric medical care that Children’s Hospital Los Angeles provides by featuring interviews with patient families, hospital leaders, celebrity supporters and sponsoring partners.

Don't Miss

INTERCEPT Blood System for Cryoprecipitation Receives FDA Approval States Cerus Corporation

The system is used to produce Pathogen Reduced Cryoprecipitated Fibrinogen Complex for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. 

Genetron Health Provides Update on HCCscreen™ for Liver Cancer Early Screening in China

Establishes joint venture with Wuxi municipal government; Expects the commercialization and revenues of HCCscreen to accelerate in China.

Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision

ProtoKinetix notes the research paper has been submitted to a prestigious journal specializing in tissue regeneration for peer review and editing.

OrganaBio to Expand Its cGMP Cell and Gene Therapy Manufacturing Facility: 19,000 Sq. Ft. Slated to Commence Operations In Q3 2021

OrganBio, a Miami-based cGMP facility, will include process development space, ISO 7 cleanrooms, state-of-the-art scientific equipment, analytics and QC laboratories, and a suite of support services to enable OrganaBio and its partners to rapidly and economically self-manufacture clinical materials. 

Stoke Therapeutics Announces Proposed Public Offering

November 18, 2020 Stoke Therapeutics, Inc., a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein...